Company news
China National Medicines Corporation Ltd. Class A (SSE:600511) news
China National Medicines Corporation Ltd. Class A news releases on 6ix. Latest, Sep 24, 2026: "China National Medicines Corporation Ltd."Announcement…
Press releases & updates
"China National Medicines Corporation Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 23, 2026
"China National Medicines Corporation Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
September 4, 2026
"China National Medicines Corporation Ltd."Announcement on Resolutions of the 41st Meeting of the 8th Board of Directors
August 19, 2026
"China National Medicines Corporation Ltd."Announcement on Opening of a Special Account for Temporarily Supplementing Working Capital with Raised Funds and Signing of a Regulatory Agreement
June 30, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
June 18, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 11, 2026
Notice on the 2nd Extraordinary General Meeting in 2026
May 28, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
May 15, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 13, 2026
Announcement on Renewing Engagement of Accounting Firm for 2026
April 29, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
April 22, 2026
Announcement on Amending Some Clauses of the Articles of Association
March 19, 2026
Announcement on Return of Raised Funds Temporarily Used to Supplement Current Capital
March 5, 2026
Announcement on Increasing Estimated Amount of Daily Related Party Transactions in 2025
December 9, 2025
Notice on Convening the 4th Extraordinary General Meeting in 2025
November 21, 2025
国药股份关于召开2025年第三季度业绩说明会的公告
November 18, 2025
Announcement on Resolutions of the 31st Meeting of the 8th Board of Directors
October 21, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 25, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
September 15, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision of the Shareholding Restructuring Reform
September 2, 2025
Notice on Convening the 3rd Extraordinary General Meeting in 2025
August 29, 2025
Announcement on Resolutions of the 28th Meeting of the 8th Board of Directors
August 20, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
August 19, 2025
Announcement on Canceling the Board of Supervisors and Amending the "Articles of Association"
July 31, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
July 7, 2025
Notice on Convening the 1st Extraordinary General Meeting in 2025
June 20, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 11, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 13, 2025
Announcement on Resolutions of the 24th Meeting of the 8th Board of Directors
April 24, 2025
Announcement on the Proposed Using Partial Idle Raised Funds to Temporarily Supplement Current Capital
March 19, 2025
Announcement on "Corporate Value and Return Enhancement" Action Plan
March 7, 2025
Announcement on Returning the Raised Funds Temporarily Used for Supplementing Current Capital in Advance
March 6, 2025
Announcement on Resolution of the 17th Meeting of the 8th Board of Supervisors
December 19, 2024
Announcement on Resolution of the 4th Extraordinary General Meeting in 2024
December 18, 2024
Announcement on Resignation and Election of Director
November 29, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 19, 2024
Indicative Announcement on Change in Equity of Shareholder with Shareholding Ratio Reaching 5%
November 13, 2024
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2024
November 8, 2024
Announcement on Resolution of the 19th Meeting of the 8th Board of Directors
October 23, 2024
Investor Relations Activity Record Form
September 30, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 13, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
September 6, 2024
Announcement on Resolutions of the 14th Meeting of the 8th Board of Supervisors
August 21, 2024
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
July 16, 2024
Notice on Convening 1st Special Shareholders' Meeting of 2024
June 28, 2024